- call +1-201-465-4211
- email sales@mrinsights.biz
The Active Pharmaceutical Ingredient (API) is the part of any drug that produces its effects. Some drugs, such as combination therapies, have multiple active ingredients to treat different symptoms or act in different ways.
Scope of the Report:
This report studies the Active Pharmaceutical Ingredient (API) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Active Pharmaceutical Ingredient (API) market by product type and applications/end industries.
The global Active Pharmaceutical Ingredient (API) market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Active Pharmaceutical Ingredient (API).
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Teva
Sun Pharmaceutical
Aurobindo Pharma
Albemarle
Sigma-Aldrich
Mylan
Allergan
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Innovative APIS Segment
Generic APIS Segment
Market Segment by Applications, can be divided into
Oncology
Diabetes
Cardiovascular Disease
Cns and Neurological Disorders
Orthopedic Disorders
Nephrology
Ophthalmology
Pulmonology
Gastrointestinal Disorders
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Active Pharmaceutical Ingredient (API) Market Overview
1.1 Product Overview and Scope of Active Pharmaceutical Ingredient (API)
1.2 Classification of Active Pharmaceutical Ingredient (API) by Types
1.2.1 Global Active Pharmaceutical Ingredient (API) Revenue Comparison by Types (2017-2023)
1.2.2 Global Active Pharmaceutical Ingredient (API) Revenue Market Share by Types in 2017
1.2.3 Innovative APIS Segment
1.2.4 Generic APIS Segment
1.3 Global Active Pharmaceutical Ingredient (API) Market by Application
1.3.1 Global Active Pharmaceutical Ingredient (API) Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Oncology
1.3.3 Diabetes
1.3.4 Cardiovascular Disease
1.3.5 Cns and Neurological Disorders
1.3.6 Orthopedic Disorders
1.3.7 Nephrology
1.3.8 Ophthalmology
1.3.9 Pulmonology
1.3.10 Gastrointestinal Disorders
1.4 Global Active Pharmaceutical Ingredient (API) Market by Regions
1.4.1 Global Active Pharmaceutical Ingredient (API) Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Active Pharmaceutical Ingredient (API) Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Active Pharmaceutical Ingredient (API) Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Active Pharmaceutical Ingredient (API) Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Active Pharmaceutical Ingredient (API) Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Active Pharmaceutical Ingredient (API) Status and Prospect (2013-2023)
1.5 Global Market Size of Active Pharmaceutical Ingredient (API) (2013-2023)
2 Manufacturers Profiles
2.1 Teva
2.1.1 Business Overview
2.1.2 Active Pharmaceutical Ingredient (API) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Teva Active Pharmaceutical Ingredient (API) Revenue, Gross Margin and Market Share (2016-2017)
2.2 Sun Pharmaceutical
2.2.1 Business Overview
2.2.2 Active Pharmaceutical Ingredient (API) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sun Pharmaceutical Active Pharmaceutical Ingredient (API) Revenue, Gross Margin and Market Share (2016-2017)
2.3 Aurobindo Pharma
2.3.1 Business Overview
2.3.2 Active Pharmaceutical Ingredient (API) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Aurobindo Pharma Active Pharmaceutical Ingredient (API) Revenue, Gross Margin and Market Share (2016-2017)
2.4 Albemarle
2.4.1 Business Overview
2.4.2 Active Pharmaceutical Ingredient (API) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Albemarle Active Pharmaceutical Ingredient (API) Revenue, Gross Margin and Market Share (2016-2017)
2.5 Sigma-Aldrich
2.5.1 Business Overview
2.5.2 Active Pharmaceutical Ingredient (API) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sigma-Aldrich Active Pharmaceutical Ingredient (API) Revenue, Gross Margin and Market Share (2016-2017)
2.6 Mylan
2.6.1 Business Overview
2.6.2 Active Pharmaceutical Ingredient (API) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Mylan Active Pharmaceutical Ingredient (API) Revenue, Gross Margin and Market Share (2016-2017)
2.7 Allergan
2.7.1 Business Overview
2.7.2 Active Pharmaceutical Ingredient (API) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Allergan Active Pharmaceutical Ingredient (API) Revenue, Gross Margin and Market Share (2016-2017)
3 Global Active Pharmaceutical Ingredient (API) Market Competition, by Players
3.1 Global Active Pharmaceutical Ingredient (API) Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Active Pharmaceutical Ingredient (API) Players Market Share
3.2.2 Top 10 Active Pharmaceutical Ingredient (API) Players Market Share
3.3 Market Competition Trend
4 Global Active Pharmaceutical Ingredient (API) Market Size by Regions
4.1 Global Active Pharmaceutical Ingredient (API) Revenue and Market Share by Regions
4.2 North America Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)
4.3 Europe Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)
4.5 South America Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)
5 North America Active Pharmaceutical Ingredient (API) Revenue by Countries
5.1 North America Active Pharmaceutical Ingredient (API) Revenue by Countries (2013-2018)
5.2 USA Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)
5.3 Canada Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)
5.4 Mexico Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)
6 Europe Active Pharmaceutical Ingredient (API) Revenue by Countries
6.1 Europe Active Pharmaceutical Ingredient (API) Revenue by Countries (2013-2018)
6.2 Germany Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)
6.3 UK Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)
6.4 France Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)
6.5 Russia Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)
6.6 Italy Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Active Pharmaceutical Ingredient (API) Revenue by Countries
7.1 Asia-Pacific Active Pharmaceutical Ingredient (API) Revenue by Countries (2013-2018)
7.2 China Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)
7.3 Japan Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)
7.4 Korea Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)
7.5 India Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)
8 South America Active Pharmaceutical Ingredient (API) Revenue by Countries
8.1 South America Active Pharmaceutical Ingredient (API) Revenue by Countries (2013-2018)
8.2 Brazil Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)
8.3 Argentina Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)
8.4 Colombia Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Active Pharmaceutical Ingredient (API) by Countries
9.1 Middle East and Africa Active Pharmaceutical Ingredient (API) Revenue by Countries (2013-2018)
9.2 Saudi Arabia Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)
9.3 UAE Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)
9.4 Egypt Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)
9.5 Nigeria Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)
9.6 South Africa Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)
10 Global Active Pharmaceutical Ingredient (API) Market Segment by Type
10.1 Global Active Pharmaceutical Ingredient (API) Revenue and Market Share by Type (2013-2018)
10.2 Global Active Pharmaceutical Ingredient (API) Market Forecast by Type (2018-2023)
10.3 Innovative APIS Segment Revenue Growth Rate (2013-2023)
10.4 Generic APIS Segment Revenue Growth Rate (2013-2023)
11 Global Active Pharmaceutical Ingredient (API) Market Segment by Application
11.1 Global Active Pharmaceutical Ingredient (API) Revenue Market Share by Application (2013-2018)
11.2 Active Pharmaceutical Ingredient (API) Market Forecast by Application (2018-2023)
11.3 Oncology Revenue Growth (2013-2018)
11.4 Diabetes Revenue Growth (2013-2018)
11.5 Cardiovascular Disease Revenue Growth (2013-2018)
11.6 Cns and Neurological Disorders Revenue Growth (2013-2018)
11.7 Orthopedic Disorders Revenue Growth (2013-2018)
11.8 Nephrology Revenue Growth (2013-2018)
11.9 Ophthalmology Revenue Growth (2013-2018)
11.10 Pulmonology Revenue Growth (2013-2018)
11.11 Gastrointestinal Disorders Revenue Growth (2013-2018)
12 Global Active Pharmaceutical Ingredient (API) Market Size Forecast (2018-2023)
12.1 Global Active Pharmaceutical Ingredient (API) Market Size Forecast (2018-2023)
12.2 Global Active Pharmaceutical Ingredient (API) Market Forecast by Regions (2018-2023)
12.3 North America Active Pharmaceutical Ingredient (API) Revenue Market Forecast (2018-2023)
12.4 Europe Active Pharmaceutical Ingredient (API) Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Active Pharmaceutical Ingredient (API) Revenue Market Forecast (2018-2023)
12.6 South America Active Pharmaceutical Ingredient (API) Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Active Pharmaceutical Ingredient (API) Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Active Pharmaceutical Ingredient (API) Picture
Table Product Specifications of Active Pharmaceutical Ingredient (API)
Table Global Active Pharmaceutical Ingredient (
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
